Brief: ChromoGenics Q1 Net Sales For Period Rise To SEK 10.7 Million
May 15 (Reuters) - ChromoGenics AB CHRO.ST :
* INTERIM REPORT JANUARY - MARCH 2019
* Q1 NET SALES FOR PERIOD AMOUNTED TO SEK 10.7 (1.9) MILLION
* Q1 GROSS PROFIT AMOUNTED TO SEK -2.6 MILLION, WHICH IS AN
IMPROVEMENT OF SEK 4.7 MILLION COMPARED TO CORRESPONDING PERIOD
IN 2018.
Source text for Eikon: ID:nWkr1G8h04
Further company coverage: CHRO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on ChromoGenics AB
See all newsBrief: Chromogenics Says Conditional Loan Of SEK 47.6 Mln Is Converted To Grant
Brief: Färna Invest Makes SEK 10/Shr Offer For Chromogenics
Brief: Chromogenics Q1 Pre-Tax Loss Widens To SEK 13.6 Mln
Brief: Chromogenics Gets First Order For North America
Brief: Chromogenics Initiates Cost Reduction Program